Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

Bladder cancer is the 4(th) most common cancer among men in the U.S. and more than half of patients experience recurrences within 5 years after initial diagnosis. Additional clinically informative and actionable biomarkers of the recurrent bladder cancer phenotypes are needed to improve screening an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cancer
Autors principals: Andrew, Angeline S., Marsit, Carmen J., Schned, Alan R., Seigne, John D., Kelsey, Karl T., Moore, Jason H., Perreard, Laurent, Karagas, Margaret R., Sempere, Lorenzo F.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485975/
https://ncbi.nlm.nih.gov/pubmed/25556547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29413
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars